4//SEC Filing
GALEN PARTNERS IV LP 4
Accession 0001209191-10-023698
CIK 0001254419other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 5:50 PM ET
Size
25.3 KB
Accession
0001209191-10-023698
Insider Transaction Report
Form 4
MEDASSETS INCMDAS
CLAUDIUS LLC
10% Owner
Transactions
- Sale
Common Stock
2010-04-26$22.71/sh−20,408$463,539→ 5,705,491 total(indirect: See FN) - Sale
Common Stock
2010-04-23$22.14/sh−61,600$1,363,935→ 5,725,899 total(indirect: See FN) - Sale
Common Stock
2010-04-22$22.11/sh−29,700$656,753→ 5,787,499 total(indirect: See FN)
GALEN PARTNERS IV LP
Other
Transactions
- Sale
Common Stock
2010-04-23$22.14/sh−61,600$1,363,935→ 5,725,899 total(indirect: See FN) - Sale
Common Stock
2010-04-22$22.11/sh−29,700$656,753→ 5,787,499 total(indirect: See FN) - Sale
Common Stock
2010-04-26$22.71/sh−20,408$463,539→ 5,705,491 total(indirect: See FN)
Transactions
- Sale
Common Stock
2010-04-22$22.11/sh−29,700$656,753→ 5,787,499 total(indirect: See FN) - Sale
Common Stock
2010-04-23$22.14/sh−61,600$1,363,935→ 5,725,899 total(indirect: See FN) - Sale
Common Stock
2010-04-26$22.71/sh−20,408$463,539→ 5,705,491 total(indirect: See FN)
Transactions
- Sale
Common Stock
2010-04-22$22.11/sh−29,700$656,753→ 5,787,499 total(indirect: See FN) - Sale
Common Stock
2010-04-26$22.71/sh−20,408$463,539→ 5,705,491 total(indirect: See FN) - Sale
Common Stock
2010-04-23$22.14/sh−61,600$1,363,935→ 5,725,899 total(indirect: See FN)
Claudius IV, LLC
Other
Transactions
- Sale
Common Stock
2010-04-26$22.71/sh−20,408$463,539→ 5,705,491 total(indirect: See FN) - Sale
Common Stock
2010-04-22$22.11/sh−29,700$656,753→ 5,787,499 total(indirect: See FN) - Sale
Common Stock
2010-04-23$22.14/sh−61,600$1,363,935→ 5,725,899 total(indirect: See FN)
Transactions
- Sale
Common Stock
2010-04-22$22.11/sh−29,700$656,753→ 5,787,499 total(indirect: See FN) - Sale
Common Stock
2010-04-23$22.14/sh−61,600$1,363,935→ 5,725,899 total(indirect: See FN) - Sale
Common Stock
2010-04-26$22.71/sh−20,408$463,539→ 5,705,491 total(indirect: See FN)
Transactions
- Sale
Common Stock
2010-04-23$22.14/sh−61,600$1,363,935→ 5,725,899 total(indirect: See FN) - Sale
Common Stock
2010-04-26$22.71/sh−20,408$463,539→ 5,705,491 total(indirect: See FN) - Sale
Common Stock
2010-04-22$22.11/sh−29,700$656,753→ 5,787,499 total(indirect: See FN)
Transactions
- Sale
Common Stock
2010-04-23$22.14/sh−61,600$1,363,935→ 5,725,899 total(indirect: See FN) - Sale
Common Stock
2010-04-22$22.11/sh−29,700$656,753→ 5,787,499 total(indirect: See FN) - Sale
Common Stock
2010-04-26$22.71/sh−20,408$463,539→ 5,705,491 total(indirect: See FN)
Footnotes (11)
- [F1]The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Funds on September 1, 2009
- [F10]The shares were sold at prices between $22.54 and $22.96. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F11]The shares are held as follows: 1,002,965 by Galen IV, 79,673 by Galen International IV, 1,397 by Employee Fund IV, 4,220,772 by Galen III, 382,514 by Galen International III and 18,170 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
- [F2]The shares were sold as follows: 5,224 shares by Galen Partners IV, L.P. ("Galen IV"), 415 shares by Galen Partners International IV, L.P. ("Galen International IV"), 7 shares by Galen Employee Fund IV, L.P. ("Employee Fund IV"), 21,986 shares by Galen Partners III, L.P. ("Galen III"), 1,992 shares by Galen Partners International III, L.P. ("Galen International III") and 76 shares by Galen Employee Fund III, L.P. ("Employee Fund III" and, collectively with Galen IV, Galen International IV, Employee Fund IV, Galen III, Galen International III, the "Funds").
- [F3]The shares were sold at prices between $22.06 and $22.22. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The shares are held as follows: 1,017,391 by Galen IV, 80,818 by Galen International IV, 1,418 by Employee Fund IV, 4,281,478 by Galen III, 388,016 by Galen International III and 18,378 by Employee Fund III. Claudius IV, L.L.C. ("Cladius IV") serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
- [F5]Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
- [F6]The shares were sold as follows: 10,835 shares by Galen IV, 861 shares by Galen International IV, 15 shares by Employee Fund IV, 45,599 shares by Galen III, 4,133 shares by Galen International III and 157 shares by Employee Fund III.
- [F7]The shares were sold at prices between $22.06 and $22.26. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F8]The shares are held as follows: 1,006,556 by Galen IV, 79,957 by Galen International IV, 1,403 by Employee Fund IV, 4,235,879 by Galen III, 383,883 by Galen International III and 18,221 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
- [F9]The shares were sold as follows: 3,591 shares by Galen IV, 284 shares by Galen International IV, 6 shares by Employee Fund IV, 15,107 shares by Galen III, 1,369 shares by Galen International III and 51 shares by Employee Fund III.
Documents
Issuer
MEDASSETS INC
CIK 0001254419
Entity typeother
Related Parties
1- filerCIK 0001203341
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 5:50 PM ET
- Size
- 25.3 KB